Y22

N/A

Report date: 2023/02/20 18:00:50
NME

Base Information

Drug NameY22
Drug Alias NameY-22
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionP-glycoprotein 1 inhibitorsBroad substrate specificity ATP-binding cassette transporter ABCG2 inhibitors
TargetsP-glycoprotein 1Broad substrate specificity ATP-binding cassette transporter ABCG2
Therapy Area/IndicationsN/A
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaPreclinical
Originator CompaniesChina Pharmaceutical University
China Registration ClassN/A

Develop Information

Active CompaniesChina Pharmaceutical University
Inactive CompaniesN/A
Active IndicationsN/A
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A